Cell Stress and Chaperones

, Volume 24, Issue 1, pp 283–287 | Cite as

Autoantibodies to heat shock proteins 60, 70, and 90 in patients with rheumatoid arthritis

  • Jagoda Mantej
  • Kinga Polasik
  • Ewa Piotrowska
  • Stefan TukajEmail author
Short Communication


Heat shock proteins (HSP) have been reported to impact immune responses and to be associated with rheumatoid arthritis (RA). Recently, we provided evidence for a role of autoantibodies to Hsp40 in patients with RA. In this study, we aimed at investigating the humoral autoimmune response to Hsp60, Hsp70, and Hsp90 in RA patients (n = 39). In comparison with healthy controls (n = 40), circulating IgG, IgM, and IgA autoantibodies against Hsp60, Hsp70, and Hsp90 were significantly increased in RA patients. Non-parametric statistical analysis, however, revealed no significant association between anti-HSP and disease activity or disease progression. On the other hand, positive correlations between serum levels of anti-Hsp60 IgG and IL-4 (Th2-like cytokine) or between serum levels of anti-Hsp90 IgG and IFN-ɣ (Th1-like cytokine) were found to be statistically significant in RA. In addition, a significant inverse correlation was found for serum levels of anti-Hsp70 IgM and TNF-α (Th1-like cytokine) in RA. Our results suggest a pronounced anti-Hsp60, anti-Hsp70, and anti-Hsp90 humoral autoimmune response in RA patients that seems not to be directly linked to RA pathophysiology, however, may have a potential modulatory impact on inflammatory status in this disease. Further investigations are needed to clarify the role of anti-HSP autoantibodies in RA.


Heat shock proteins, HSP Rheumatoid arthritis, RA Autoantibodies 



We are grateful to Prof. Ewa Bryl and Prof. Jacek M. Witkowski from the Medical University of Gdańsk for providing us sera samples from RA patients.

Funding information

This study was supported by the Polish National Science Centre (NCN), grant no. 2017/25/B/NZ6/00305.

Compliance with ethical standards

The use of human biological material was approved by the Ethics Committee of the Medical University of Gdańsk, Poland, and written informed consent was obtained according to the Declaration of Helsinki.


  1. Chandawarkar RY, Wagh MS, Kovalchin JT, Srivastava P (2004) Immune modulation with high-dose heat-shock protein gp96: therapy of murine autoimmune diabetes and encephalomyelitis. Int Immunol 16:615–624CrossRefGoogle Scholar
  2. Guo Q, Wang Y, Xu D, Nossent J, Pavlos NJ, Xu J (2018) Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Res 6:15. CrossRefPubMedCentralGoogle Scholar
  3. Kampinga HH, Hageman J, Vos MJ, Kubota H, Tanguay RM, Bruford EA, Cheetham ME, Chen B, Hightower LE (2009) Guidelines for the nomenclature of the human heat shock proteins. Cell Stress Chaperones 14:105–111. CrossRefGoogle Scholar
  4. Kasperkiewicz M, Tukaj S, Gembicki AJ, Silló P, Görög A, Zillikens D, Kárpáti S (2014) Evidence for a role of autoantibodies to heat shock protein 60, 70, and 90 in patients with dermatitis herpetiformis. Cell Stress Chaperones 9:837–843. CrossRefGoogle Scholar
  5. Koffeman EC, Genovese M, Amox D, Keogh E, Santana E, Matteson EL, Kavanaugh A, Molitor JA, Schiff MH, Posever JO, Bathon JM, Kivitz AJ, Samodal R, Belardi F, Dennehey C, van den Broek T, van Wijk F, Zhang X, Zieseniss P, le T, Prakken BA, Cutter GC, Albani S (2009) Epitope-specific immunotherapy of rheumatoid arthritis: clinical responsiveness occurs with immune deviation and relies on the expression of a cluster of molecules associated with T cell tolerance in a double-blind, placebo-controlled, pilot phase II trial. Arthritis Rheum 60:3207–3216. CrossRefGoogle Scholar
  6. Kotlarz A, Tukaj S, Krzewski K, Brycka E, Lipinska B (2013) Human Hsp40 proteins, DNAJA1 and DNAJA2, as potential targets of the immune response triggered by bacterial DnaJ in rheumatoid arthritis. Cell Stress Chaperones 18:653–659.
  7. Liu Z, Li X, Qiu L, Zhang X, Chen L, Cao S, Wang F, Meng S (2009) Treg suppress CTL responses upon immunization with HSP gp96. Eur J Immunol 39:3110–3120. CrossRefGoogle Scholar
  8. Pockley AG, Shepherd J, Corton JM (1998) Detection of heat shock protein 70 (Hsp70) and anti-Hsp70 antibodies in the serum of normal individuals. Immunol Investig 27:367–377CrossRefGoogle Scholar
  9. Pockley AG, Bulmer J, Hanks BM, Wright BH (1999) Identification of human heat shock protein 60 (Hsp60) and anti-Hsp60 antibodies in the peripheral circulation of normal individuals. Cell Stress Chaperones 4:29–35CrossRefGoogle Scholar
  10. Quintana FJ, Carmi P, Mor F, Cohen IR (2004) Inhibition of adjuvant-induced arthritis by DNA vaccination with the 70-kd or the 90-kd human heat-shock protein: immune cross-regulation with the 60-kd heat-shock protein. Arthritis Rheum 50:3712–3720. CrossRefGoogle Scholar
  11. Spierings J, van Eden W (2017) Heat shock proteins and their immunomodulatory role in inflammatory arthritis. Rheumatology (Oxford) 56:198–208. CrossRefGoogle Scholar
  12. Srivastava P (2002) Roles of heat-shock proteins in innate and adaptive immunity. Nat Rev Immunol 2:185–194. CrossRefGoogle Scholar
  13. Trepel J, Mollapour M, Giaccone G, Neckers L (2010) Targeting the dynamic HSP90 complex in cancer. Nat Rev Cancer 10:537–549. CrossRefGoogle Scholar
  14. Tukaj S (2014) Immunoregulatory properties of Hsp70. Postepy Hig Med Dosw 68:722–727CrossRefGoogle Scholar
  15. Tukaj S, Węgrzyn G (2016) Anti-Hsp90 therapy in autoimmune and inflammatory diseases: a review of preclinical studies. Cell Stress Chaperones 21:213–218. CrossRefPubMedCentralGoogle Scholar
  16. Tukaj S, Kotlarz A, Jozwik A, Smolenska Z, Bryl E, Witkowski JM, Lipinska B (2010a) Hsp40 proteins modulate humoral and cellular immune response in rheumatoid arthritis patients. Cell Stress Chaperones 15:555–566. CrossRefPubMedCentralGoogle Scholar
  17. Tukaj S, Kotlarz A, Jóźwik A, Smoleńska Z, Bryl E, Witkowski JM, Lipińska B (2010b) Cytokines of the Th1 and Th2 type in sera of rheumatoid arthritis patients; correlations with anti-Hsp40 immune response and diagnostic markers. Acta Biochim Pol 57:327–332Google Scholar
  18. Tukaj S, Görög A, Kleszczyński K, Zillikens D, Kárpáti S, Kasperkiewicz M (2017) Autoimmunity to heat shock proteins and vitamin D status in patients with celiac disease without associated dermatitis herpetiformis. J Steroid Biochem Mol Biol 173:23–27. CrossRefGoogle Scholar
  19. Ulmansky R, Cohen CJ, Szafer F, Moallem E, Fridlender ZG, Kashi Y, Naparstek Y (2002) Resistance to adjuvant arthritis is due to protective antibodies against heat shock protein surface epitopes and the induction of IL-10 secretion. J Immunol 168:6463–6469CrossRefGoogle Scholar
  20. Ulmansky R, Landstein D, Moallem E, Loeb V, Levin A, Meyuhas R, Katzavian G, Yair S, Naparstek Y (2015) A humanized monoclonal antibody against heat shock protein 60 suppresses murine arthritis and colitis and skews the cytokine balance toward an anti-inflammatory response. J Immunol 194:5103–5109CrossRefGoogle Scholar
  21. van Eden W, van der Zee R, Prakken B (2005) Heat-shock proteins induce T-cell regulation of chronic inflammation. Nat Rev Immunol 5:318–330CrossRefGoogle Scholar
  22. van Eden W, Jansen MAA, Ludwig I, van Kooten P, van der Zee R, Broere F (2017) The enigma of heat shock proteins in immune tolerance. Front Immunol 8:1599. CrossRefPubMedCentralGoogle Scholar
  23. van Herwijnen MJ, Wieten L, van der Zee R et al (2012) Regulatory T cells that recognize a ubiquitous stress-inducible self-antigen are long-lived suppressors of autoimmune arthritis. Proc Natl Acad Sci U S A 109:14134–14139. CrossRefPubMedCentralGoogle Scholar
  24. Wieten L, Berlo SE, Ten Brink CB, van Kooten PJ, Singh M, van der Zee R, Glant TT, Broere F, van Eden W (2009) IL-10 is critically involved in mycobacterial HSP70 induced suppression of proteoglycan-induced arthritis. PLoS One 4:e4186. CrossRefPubMedCentralGoogle Scholar

Copyright information

© Cell Stress Society International 2018

Authors and Affiliations

  1. 1.Department of Molecular Biology, Faculty of BiologyUniversity of GdańskGdańskPoland

Personalised recommendations